Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV

Journal of Infectious Diseases

Volumn 196, Issue 3, 2007, Pages 361-370

  Letendre, Scott ^a,e,f,g   Paulino, Amy D ^b   Rockenstein, Edward ^b   Adame, Anthony ^b   Crews, Leslie ^c   Cherner, Mariana ^d,e,f,g   Heaton, Robert ^c,e,f,g   Ellis, Ronald ^b,e,f,g   Everall, Ian P ^d   Grant, Igor ^d,e,f,g   Masliah, Eliezer ^b,c,e,f,g   Atkinson, J Hampton ^e,f,g   McCutchan, J Allen ^e,f,g   Marcotte, Thomas D ^e,f,g   Wallace, Mark R ^e,f,g   Schier, Rachel ^e,f,g   Jernigan, Terry ^e,f,g   Hesselink, John ^e,f,g   Masys, Daniel R ^e,f,g   Frybarger, Michelle ^e,f,g   Abramson, Tan ^e,f,g   Deutsch, Reena ^e,f,g   Wolfson, Tanya ^e,f,g   more..

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NEUROPATHOLOGY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS ENCEPHALITIS;

ADULT; ANTIGENS, VIRAL; BRAIN; ENCEPHALITIS, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; NEUROGLIA; RNA, VIRAL;

EID: 34447624306     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519285     Document Type: Article

References (50)

1. Deutsch R, Ellis RJ, McCutchan JA, Marcotte TD, Letendre S, Grant I. AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS 2001; 15:1898-9.
2. Suarez S, Baril L, Stankoff B, et al. Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS 2001; 15:195-200.
3. Gray F, Chretien F, Vallat-Decouvelaere AV, Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003; 62:429-40.
4. Antinori A, Perno CF, Giancola ML, et al. Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma. Clin Infect Dis 2005; 41:1787-93.
5. Letendre SL, McCutchan JA, Childers ME, et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 2004; 56:416-23.
6. Eggers C, Hertogs K, Sturenburg HJ, van Lunzen J, Stellbrink HJ. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration. AIDS 2003; 17:1897-906.
7. Strain MC, Letendre S, Pillai SK, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005; 79:1772-88.
8. Farabee D, Prendergast M, Cartier J. Methamphetamine use and HIV risk among substance-abusing offenders in California. J Psychoactive Drugs 2002; 34:295-300.
9. Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004; 10:1-14.
10. Chang L, Speck O, Miller EN, et al. Neural correlates of attention and working memory deficits in HIV patients. Neurology 2001; 57:1001-7.
11. Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 2005; 19(Suppl 3):S72-8.
12. Kim AY, Chung RT, Polsky B. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy. AIDS Clin Rev 2000-2001:263-306.
13. Bolay H, Soylemezoglu F, Nurlu G, Tuncer S, Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg 1996; 98:305-8.
14. Caudai C, Maimone D, Almi P, et al. The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C. Gut 1997; 41:411-2.
15. Maggi F, Giorgi M, Fornai C, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999; 5:319-23.
16. Laskus T, Radkowski M, Bednarska A, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002; 76:10064-8.
17. Radkowski M, Wilkinson J, Nowicki M, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002; 76:600-8.
18. Vargas HE, Laskus T, Radkowski M, et al. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002; 8:1014-9.
19. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38-9.
20. Taylor MJ, Letendre SL, Schweinsburg BC, et al. Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc 2004; 10:110-3.
21. Cherner M, Letendre S, Heaton RK, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005; 64:1343-7.
22. Laskus T, Radkowski M, Jablonska J, et al. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 2004; 103:3854-9.
23. Eisen-Vandervelde AL, Yao ZQ, Hahn YS. The molecular basis of HCV-mediated immune dysregulation. Clin Immunol 2004; 111:16-21.
24. Walters KA, Smith MW, Pal S, et al. Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV-and HCV/HIV-infected individuals. Virology 2006; 350:453-64.
25. Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004; 62:957-62.
26. Heaton RK, Grant I, Butters N, et al. The HNRC 500 - neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995; 1:231-51.
27. Langford D, Adame A, Grigorian A, et al. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 2003; 34:467-74.
28. Langford D, Marquie-Beck J, de Almeida S, et al. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol 2006; 12:100-7.
29. Krekulova L, Rehak V, Wakil AE, Harris E, Riley LW. Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype lb from other genotypes. J Clin Microbiol 2001; 39:1774-80.
30. Takeuchi T, Katsume A, Tanaka T, et al. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999; 116:636-42.
31. Zahn A, Allain JP. Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol 2005; 86:677-85.
32. Langford D, Grigorian A, Hurford R, et al. Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol 2004; 63:1038-47.
33. Masliah E, Achim C, Ge N, DeTeresa R, Terry R, Wiley C. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992; 32:321-9.
34. Cherner M, Masliah E, Ellis RJ, et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 2002; 59:1563-7.
35. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78:5170-83.
36. Forton DM, Thomas HC, Taylor-Robinson SD. Central nervous system involvement in hepatitis C virus infection. Metab Brain Dis 2004; 19:383-91.
37. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442-8.
38. Bronowicki JP, Loriot MA, Thiers V, Grignon Y, Zignego AL, Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 1998; 28:211-8.
39. Morsica G, Bernardi MT, Novati R, Uberti Foppa C, Castagna A, Lazzarin A. Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol 1997; 53:252-4.
40. Laskus T, Radkowski M, Wang LF, Jang SJ, Vargas H, Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 1998; 248:164-71.
41. Miyanari Y, Hijikata M, Yamaji M, Hosaka M, Takahashi H, Shimotohno K. Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J Biol Chem 2003; 278:50301-8.
42. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998; 72:1640-6.
43. Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J. Emerging evidence of hepatitis C virus neuroinvasion. AIDS 2005; 19(Suppl 3):S140-4.
44. Roque Afonso AM, Jiang J, Penin F, et al. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol 1999; 73:9213-21.
45. Adair DM, Radkowski M, Jablonska J, et al. Differential display analysis of gene expression in brains from hepatitis C-infected patients. AIDS 2005; 19(Suppl 3):S145-50.
46. Ferbeyre G, Bourdeau V, Cedergren R. Does HIV tat protein also regulate genes of other viruses present in HIV infection? Trends Biochem Sci 1997; 22:115-6.
47. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997; 11:1421-31.
48. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999; 13:1-22.
49. Chan H, Butterworth RF. Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy. Neurochem Res 1999; 24:1397-401.
50. Wang Z, Trillo-Pazos G, Kim SY, et al. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 2004; 10(Suppl 1):25-32.